Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Glucose priming may improve tumor targeting for chemotherapy nanocarriers (opens in a new tab)

news-medical.net · 2026-10-21

Short answerEvidenceSource

Short answer

Not assessed

Check incomplete.

We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Source study identified.

A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.

View article claims
3

The source study

Metabolically Enhanced pH-Dependent Conformational Switching of Polymers for Selective Chemotherapy of Solid Tumors: A Hypothesis

Exploratory Research and Hypothesis in Medicine · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.

Claim 1 of 6Not checkedThe central hypothesis is that controlled glucose priming, timed with nanocarrier administration, may transiently widen the tumor-to-normal pH differential enough to trigger release from a sharply tuned ultra-pH-sensitive (UPS) carrier.View evidenceHide evidence

As statedreported tumor pH decreases of about 0.17 to 0.20 units; UPS transition window less than 0.25 pH unit

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 2 of 6Not checkedChemotherapy selectivity is limited by systemic toxicity, and pH-sensitive nanocarriers exploit tumor acidity as a release trigger but respond passively to a modest, heterogeneous gradient.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 3 of 6Not checkedThe article says the key uncertainty is perfusion: blood flow was unchanged at 1 g/kg glucose but reduced by 31% at 4 g/kg, while perfusion at 2 g/kg is uncharacterized.View evidenceHide evidence

As stated31% flow reduction at 4 g/kg; no change at 1 g/kg

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 4 of 6Not checkedA prior pHLIP-liposome study is cited as supporting the general principle, but the article says it uses a mechanistically distinct carrier from the proposed UPS polymers.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 5 of 6Not checkedAnimal studies are described as reporting tumor pH decreases of about 0.17 at 1 g/kg and about 0.60 at 4 g/kg, with nadir at 30 to 60 minutes and recovery by about 90 minutes; in 25 patients given 100 g oral glucose, mean change was about -0.17 ± 0.04 units but heterogeneous.View evidenceHide evidence

As stated-0.17 at 1 g/kg; -0.60 at 4 g/kg; 25 patients; -0.17 ± 0.04

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Claim 6 of 6Not checkedThe article concludes that the strategy should be treated as a falsifiable preclinical proposal rather than a clinically feasible protocol until simultaneous, spatially resolved measurements of pH, perfusion, carrier accumulation, and cargo release are done across doses and sequences.View evidenceHide evidence

Not checked

A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Metabolically Enhanced pH-Dependent Conformational Switching of Polymers for Selective Chemotherapy of Solid Tumors: A Hypothesis

Exploratory Research and Hypothesis in Medicine · 2026

Source record (opens in a new tab)

Why this one

Confident

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

Selected

Metabolically Enhanced pH-Dependent Conformational Switching of Polymers for Selective Chemotherapy of Solid Tumors: A Hypothesis

Exploratory Research and Hypothesis in Medicine · 2026 · Crossref

Source (opens in a new tab)
Candidate

Lysosomal disruptive nanocarrier based on pH-sensitive charge-reversal for tumor targeted anticancer drug delivery

Journal of Controlled Release · 2017 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.